# Arbutus Biopharma Corp: Form 8-K, filed May 20, 2019

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2019-05-20
- Accepted by EDGAR: May 20, 2019, 06:07 ET
- Period: 2019-05-20
- Accession: 0001104659-19-030387
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000110465919030387/a19-10243_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000110465919030387/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000110465919030387/a19-10243_18k.htm

Filed May 20, 2019.
Source: SEC EDGAR, the filing index for accession 0001104659-19-030387. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.